The acquisition marks USV’s strategic entry into the rapidly expanding consumer wellness space, as per the Moneycontrol report. The move is expected to accelerate the Mumbai-based pharmaceutical firm’s presence in segments driven by premium nutrition, preventive healthcare, and digitally led purchasing trends, while complementing its future focus on innovation-oriented therapies such as GLP-1.
Wellbeing Nutrition has emerged as a fast-growing premium player known for its science-backed, clean-label offerings, including capsules, melts, effervescent tablets, and whole-food-based formulations. The brand has built a strong D2C footprint supported by innovative delivery formats and high-quality natural ingredient sourcing.
According to company projections, Wellbeing Nutrition has recorded approximately 120 percent growth over the past two years and is on track to surpass Rs 450 crore in revenue by FY27. The startup has also attracted early investments from prominent backers such as Hindustan Unilever and Fireside Ventures.
The company has established an omni-channel presence spanning its own digital platforms alongside broader retail availability, strengthening its positioning within India’s premium nutraceutical market.
Also Read: USV Launches Concordance Tool to Empower Gestational Diabetes Care in India
USV Managing Director Prashant Tewari described the acquisition as a forward-looking expansion aligned with evolving consumer preferences for proactive wellness. He noted that Wellbeing Nutrition’s emphasis on clinically supported products and transparency resonates with USV’s longstanding quality standards.
Wellbeing Nutrition Founder Avnish Chhabria stated that the partnership would enable the company to scale operations while preserving its science-led and consumer-centric philosophy. He highlighted that USV’s manufacturing expertise and global quality systems would support the brand’s next phase of growth, reports MoneyControl.
Founded in 1961, USV ranks among India’s established pharmaceutical companies, reporting FY25 revenues of Rs 5,200 crore and employing over 7,000 people. The company holds a strong position in oral anti-diabetics and cardiovascular therapies, with key brands including Glycomet, Ecosprin, Roseday, and Jalra. USV is also the exclusive marketer of the German skincare brand Sebamed in India.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.